XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Assets and Liabilities - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Investments at fair value:    
Investments at fair value $ 353,676,708 $ 376,992,972 [1]
Interest receivable 4,207,137 3,291,794
Cash 3,321,696 5,045,540
Deferred financing cost 706,395 846,916
Paydown receivable 583,278 1,068,839
Total assets 362,495,214 387,246,061
LIABILITIES    
Credit facility payable 149,500,000 176,500,000
Subscriptions received in advance 6,246,250 0
Incentive fees payable, net of fee waivers (Note 6) 5,186,994 3,961,476
Redemptions payable 4,872,739 4,700,693
Credit facility interest payable 3,382,731 3,645,612
Management fees payable, net of fee waivers (Note 6) 1,152,067 1,121,412
Professional fees payable 555,322 308,137
Other payables 346,159 368,999
Legal fees payable 63,480 26,962
Reimbursement expense payable 36,341 79,070
Distributions payable 0 6,073,111
Total liabilities 171,342,083 196,785,472
Commitments and contingencies (Note 11)
NET ASSETS    
Common shares, $0.001 par value (200,000,000 shares authorized, 7,615,428 and 7,687,482 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively) 7,616 7,688
Contribution receivable 0 (110,891)
Additional paid-in capital 189,822,985 191,646,036
Accumulated undistributed (overdistributed) earnings 1,322,530 (1,082,244)
Total net assets $ 191,153,131 $ 190,460,589
Net asset value per share (in dollars per share) $ 25.1 $ 24.78
Non-controlled/Non-affiliated Investments [Member]    
Investments at fair value:    
Investments at fair value $ 344,632,380 $ 367,622,559
Controlled/Affiliate Investments [Member]    
Investments at fair value:    
Investments at fair value $ 9,044,328 $ 9,370,413
[1] Because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Company’s board of directors (the “Board”) as required by the 1940 Act. See Note 4 “Fair Value Measurements” in the accompanying notes to the consolidated financial statements.